Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Octreotide acetate |
Is a |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide adverse reaction (disorder) |
Causative agent (attribute) |
True |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing octreotide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to octreotide |
Causative agent (attribute) |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 50micrograms/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 100micrograms/1mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 500micrograms/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 1mg/5mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 10mg depot injection+solvent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 20mg powder and solvent for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 30mg depot injection+solvent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 1mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Single photon emission computed tomography using radiolabelled octreotide |
Using substance (attribute) |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Single photon emission computed tomography using radiolabelled octreotide |
Using substance (attribute) |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to octreotide |
Causative agent (attribute) |
True |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Radiolabelled octreotide |
Is a |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Indium (111-In) labelled octreotide |
Is modification of (attribute) |
True |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate |
Is modification of (attribute) |
True |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Octreotide (as octreotide acetate) 30 mg powder for suspension for injection vial |
Has basis of strength substance (attribute) |
True |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely octreotide (as octreotide acetate) 100 microgram/1 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely octreotide (as octreotide acetate) 1 milligram/5 milliliter conventional release solution for injection vial |
Has basis of strength substance (attribute) |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely octreotide (as octreotide acetate) 500 microgram/1 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely octreotide (as octreotide acetate) 50 microgram/1 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Octreotide-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Octreotide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only octreotide in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely octreotide (as octreotide acetate) 200 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely octreotide (as octreotide acetate) 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Octreotide (as octreotide acetate) 50 microgram/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely octreotide (as octreotide acetate) 100 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Radiolabelled octreotide |
Is modification of (attribute) |
True |
Octreotide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|